Date: 2016-03-16
Type of information: Establishment of a new subsidiary in the EU
Compound: JLINX
Company: Johnson & Johnson Innovation, Janssen Pharmaceuticals, a J&J company (USA - NJ)
Therapeutic area:
Type agreement: establishment of a new subsidiary in the EU
Action mechanism:
Disease:
Details: * On March 16, 2016, Johnson & Johnson Innovation launched Johnson & Johnson Innovation, JLINX. The company is expanding its company incubation strategy to include a new multifaceted initiative in Europe designed to identify and nurture early-stage companies actively pursuing research with the potential to transform human health. JLINX is designed to catalyze scientific innovations by offering start-ups flexible ways to grow and collaborate across the European life science ecosystem. It will be located in a fully dedicated facility on the Janssen campus in Beerse, Belgium, and will be managed through a close collaboration between Johnson & Johnson Innovation and bioqube ventures, which will provide independent oversight for venture funding and company selection. JLINX will provide entrepreneurs with opportunities to share ideas and collaborate with each other while accessing a unique combination of resources including investment, infrastructure, and access to relevant internal and external scientific, technical and business expertise. The new initiative is accepting applications immediately and will be fully operational by this summer. Johnson & Johnson Innovation will work closely with bioqube ventures which will provide an experienced management team to run the day to day operations of JLINX, including managing the investment portfolio and relationships with external venture investors, involvement in identifying and securing new companies, and supporting the overall scale-up of the new initiative. In alignment with the recently launched Janssen Human Microbiome Institute, JLINX will have a particular focus on human microbiome research, alongside other areas of innovation in pharmaceuticals and cross-disciplinary healthcare solutions.
Financial terms:
Latest news:
